Related references
Note: Only part of the references are listed.Frequency and profile of Parkinson's disease prodromi in patients with malignant melanoma
Uwe Walter et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2016)
PARKIN Inactivation Links Parkinson's Disease to Melanoma
Hui-Han Hu et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
PARKIN Inactivation Links Parkinson's Disease to Melanoma
Hui-Han Hu et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
Reducing tau aggregates with anle138b delays disease progression in a mouse model of tauopathies
Jens Wagner et al.
ACTA NEUROPATHOLOGICA (2015)
Anle138b and related compounds are aggregation specific fluorescence markers and reveal high affinity binding to ot-synuclein aggregates
Andreas A. Deeg et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2015)
Autophagy in malignant transformation and cancer progression
Lorenzo Galluzzi et al.
EMBO JOURNAL (2015)
Dysregulation of redox-state-regulating enzymes in melanocytic skin tumours and the surrounding microenvironment
Hanna-Riikka Hintsala et al.
HISTOPATHOLOGY (2015)
The role for autophagy in cancer
Eileen White
JOURNAL OF CLINICAL INVESTIGATION (2015)
Atg7 Overcomes Senescence and Promotes Growth of BrafV600E-Driven Melanoma
Xiaoqi Xie et al.
CANCER DISCOVERY (2015)
DJ-1: a promising marker in metastatic uveal melanoma
Li-Li Chen et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2015)
Parkinson's Disease and Cancer: A Register-based Family Study
Karin Wirdefeldt et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2014)
Development of potent autophagy inhibitors that sensitize oncogenic BRAF V600E mutant melanoma tumor cells to vemurafenib
Megan L. Goodall et al.
AUTOPHAGY (2014)
Targeting ER stress-induced autophagy overcomes BRAF inhibitor resistance in melanoma
Xiao-Hong Ma et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Prognostic Impact of p62 Expression in Cutaneous Malignant Melanoma
Robert A. Ellis et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2014)
Autophagy and mitophagy interplay in melanoma progression
Hannelore Maes et al.
MITOCHONDRION (2014)
Susceptibility loci for pigmentation and melanoma in relation to Parkinson's disease
Jing Dong et al.
NEUROBIOLOGY OF AGING (2014)
ATP13A2 and Alpha-synuclein: a Metal Taste in Autophagy
Tomás Lopes da Fonseca et al.
Experimental Neurobiology (2014)
Anle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson's disease
Jens Wagner et al.
ACTA NEUROPATHOLOGICA (2013)
Role of Ser129 phosphorylation of α-synuclein in melanoma cells
Byung Rho Lee et al.
JOURNAL OF CELL SCIENCE (2013)
Shared Predispositions of Parkinsonism and Cancer A Population-Based Pedigree-Linked Study
Seth A. Kareus et al.
ARCHIVES OF NEUROLOGY (2012)
No Association between Parkinson Disease Alleles and the Risk of Melanoma
Shasha Meng et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2012)
Deconvoluting the context-dependent role for autophagy in cancer
Eileen White
NATURE REVIEWS CANCER (2012)
Parkinson Disease and Malignant Melanoma in First-degree Relatives of Patients With Early-onset Melanoma
Jorgen H. Olsen et al.
EPIDEMIOLOGY (2011)
α-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells
Christian Hansen et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
α-Synuclein Expression Selectively Affects Tumorigenesis in Mice Modeling Parkinson's Disease
Eitan Israeli et al.
PLOS ONE (2011)
Increased Melanoma Risk in Parkinson Disease A Prospective Clinicopathological Study
John M. Bertoni et al.
ARCHIVES OF NEUROLOGY (2010)
Parkinson's disease and cancer risk: a systematic review and meta-analysis
Archna Bajaj et al.
CANCER CAUSES & CONTROL (2010)
Beclin 1 and LC3 autophagic gene expression in cutaneous melanocytic lesions
Clelia Miracco et al.
HUMAN PATHOLOGY (2010)
Induction of Autophagy and Inhibition of Melanoma Growth In Vitro and In Vivo by Hyperactivation of Oncogenic BRAF
Nityanand Maddodi et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2010)
Skin Cancer and Parkinson's Disease
Joaquim J. Ferreira et al.
MOVEMENT DISORDERS (2010)
Common pathogenic pathways in melanoma and Parkinson disease
Coro Paisan-Ruiz et al.
NEUROLOGY (2010)
Parkinson's Disease-Related Protein, α-Synuclein, in Malignant Melanoma
Yasuhiro Matsuo et al.
PLOS ONE (2010)
Autophagic cell death: the story of a misnomer
Guido Kroemer et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
The role of N-cadherin, MCAM and β3 integrin in melanoma progression, proliferation, migration and invasion
Kelly Watson-Hurst et al.
CANCER BIOLOGY & THERAPY (2006)
The characterization of the invasion phenotype of uveal melanoma tumour cells shows the presence of MUC18 and HMG-1 metastasis markers and leads to the identification of DJ-1 as a potential serum biomarker
Maria Pardo et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Whole-genome expression profiling of the melanoma progression pathway reveals marked molecular differences between nevi/melanoma in situ and advanced-stage melanomas
AP Smith et al.
CANCER BIOLOGY & THERAPY (2005)
Share Paper
